Sociodemographic factors may influence cancer survivors’ ability to access pharmacologic treatment for mental health conditions, according to study results.

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear.

Among patients with hormone receptor-positive (HR+), HER2-negative (HER2-) early breast cancer, the 70-gene profiling test MammaPrint has been found to be predictive of both distant recurrence-free interval prognosis and chemotherapy benefit, researcher has shown.

Primary care physicians may be underutilized in follow-up and surveillance of individuals with cancer.

Computed tomography (CT) scans are an important tool for diagnosing conditions and injuries by creating three-dimensional images.

Many Americans take a dark view of nicotine. The stimulant, which occurs naturally in tobacco plants, is what makes cigarettes so addictive, with smoking responsible for 490,000 American deaths each year.

Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but that only buys time.

Diagnoses of prostate cancer rose by 3% annually between 2014 and 2021, following year-over-year declines of 6.4% in the late 2000s and early 2010s, according to the latest statistics from the American Cancer Society (ACS).

Sucralose, a sweetener found in many diet sodas, low-calorie snacks and powdered sugar substitutes, could interfere with immunotherapy in cancer patients, according to research from the University of Pittsburgh and UPMC Hillman Cancer Center.

When TV personality Danielle Lloyd was diagnosed with melanoma earlier this year, she faced not only the anxiety of cancer treatment but also a disturbing reality: influencers spreading dangerous misinformation about sun protection.